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Abstract. 
The relationships between executive processes, associative learning and 
different aspects of real world memory functioning were explored in a sample of 
cannabis users and nonusers. Measures of executive component processes, associative 
learning, everyday memory, prospective memory, and cognitive failures were 
administered. Relative to nonusers, cannabis users were found to be impaired in 
several aspects of real world memory functioning. No other group differences were 
apparent. The absence of cannabis related deficits in those executive component 
processes and aspects of learning that are believed to support real world memory 
processes is surprising given that cannabis related deficits were obtained in real world 
memory. The present results are discussed within the context of neuroimaging 
evidence which suggests that cannabis users may exhibit different patterns of neural 
activation when performing executive tasks while not always exhibiting deficits on 
these tasks. 
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The focus of the present paper is real world memory functioning in abstinent 
cannabis users. More specifically we intend to explore the basis of cannabis-related 
deficits in prospective memory, everyday memory, and cognitive failures, and the 
extent to which these impairments are underpinned by deficits in pre-frontal executive 
processes. Given that cannabis is clearly the most popular illicit drug in North 
America, Europe and in other parts of the world (Andersson et al, 2005) it is of 
considerable importance to investigate whether consumption of the drug is associated 
with cognitive deficits.  
Cannabis contains a number of chemical compounds collectively known as 
cannabinoids. The psychoactive properties of cannabis are mainly due to one of these 
cannabinoids, Δ9 tetrahydrocannabinol, (THC). Animal studies have revealed that 
chronic administration of THC causes hippocampal damage and impairs maze 
learning in rats (Fehr et al, 1976; Lawston et al, 2000). In humans, cannabinoids may 
be neurotoxic or neuroprotective depending on their concentration, the timing of 
delivery and the cell type (Doble, 1999; Guzman et al, 2001; Hubert & Doble, 1998).  
It has been suggested that even small residual amounts of cannabinoids have the 
potential to cause neurotoxicity (Sarne et al, 2005; Sarne & Keren 2004). This raises 
the possibility that even occasional cannabis users might be at risk of neurological and 
consequent cognitive impairment. 
Consistent with this possibility, Verdejo-Garcia et al (2006) reported that 
cannabis users might be impaired in aspects of executive functioning such as 
planning, working memory, and mental flexibility. Recall seems to be one area of 
cognition that is subject to cannabis-related deficits. Schwartz (1991) found that daily 
cannabis users exhibited impaired immediate recall on the Wechsler Memory Scale 
(WMS). Although slightly attenuated at 6-week retest, the cannabis-related deficit 
remained apparent. Similarly deficits among cannabis users were found on aspects of 
the Rey Auditory Verbal Learning Test (Solowij et al, 2002), verbal memory 
(Messinis et al, 2006), the retrieval of certain types of word stimuli (Block & 
Ghoneim, 1993), and visuo-spatial recall (Varma et al, 1988). More generally, 
performance on a range of cognitive tasks appeared to deteriorate with increasing 
years of heavy frequent cannabis use (Messinis et al, 2006). Impairments appeared to 
persist for at least at least 6 weeks following last ingestion of cannabis (Schwartz, 
1991) and were especially evident in female (but not male) heavy users (Pope et al, 
1997).  
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The existence of these laboratory-based deficits in basic memory processes 
raises the possibility that aspects of real world memory functioning including 
everyday memory, prospective memory, and the propensity for cognitive failures 
might be adversely affected among cannabis users. For example cannabis users might 
be more likely to forget the location of familiar objects around the house, forget to 
take essential objects when leaving the home or office, fail to recognise 
acquaintances, or forget important events that occurred the previous day, etc. These 
are all capacities that are assessed in established measures of everyday memory 
(Sunderland et al, 1983) or cognitive failures (Broadbent et al, 1982). An additional 
aspect of memory that is of relevance beyond laboratory contexts is prospective 
memory. This involves remembering to execute a particular behavior at some future 
point in time which may be in the short term or more long term, for example 
remembering to turn off the lights when leaving a room or remembering to attend a 
meeting, meet a friend or pass on a message. Measures of this construct have also 
been developed (e.g., Hannon et al, 1995). However, these aspects of real world 
memory remain under-investigated among cannabis users. Clearly the cannabis-
related recall impairments evident in laboratory contexts are likely to be manifested 
outside the laboratory in real world situations. However, cognitive failures and 
prospective memory are also dependent on prefrontal executive processes as well as 
the medial temporal-hippocampal processes which support memory functions 
(Goldstein & Polkey 1992; Kliegel et al 2005; West, 1996). Planning and monitoring 
are important aspects of real world memory and clearly also draw on executive 
resources. Indeed, clear evidence of prefrontal involvement in real world memory 
tasks has been obtained (Marsh & Hicks, 1998; McDaniel et al, 1999; Whyte et al, 
2006).  
Thus cannabis-related deficits in real world memory may arise from traditional 
memory processes and/or as a result of pre-frontal impairments. A key aim of the 
present paper is to establish whether the cannabis-related deficits in memory 
processes that have been documented in the laboratory generalise to real world 
contexts. If so, the present paper will also seek to establish whether cannabis-related 
deficits in executive processes might also affect real world memory performance. 
Thus a range of laboratory based measures of executive functioning and learning, as 
well as self report measures of aspects of real world memory were administered. The 
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performance of cannabis users (with no history of other illicit drug use) on these 
measures was compared with that of drug naïve individuals. 
 
METHOD 
Participants. Those participating in the Study were selected from an existing 
database containing a range of measures for substance abusers and drug naïve 
individuals. Cannabis users were selected on the basis that cannabis was the only 
illicit substance used. Thus polydrug users who consumed cannabis and other illicit 
drugs such as cocaine and ecstasy were excluded. Non users were those who indicated 
that they had never used any illicit drug. Both groups included individuals who 
consumed alcohol and tobacco. As the database was constructed over a period of 
years the number of users and nonusers completing the various measures varied. 
Sample sizes for each of the measures are included in Table 1. Members of the 
database were recruited via direct approach to university students, and the snowball 
technique. The mean ages for the different samples ranged between 20 to 22 years for 
non users and consistently 21 years for users. Participants were requested to refrain 
from cannabis use for at least 24 hours prior to testing. The mean and median periods 
of abstinence for cannabis users in each sample are set out in Table 1. The samples 
contributing to the different measures overlapped to a substantial degree. For 
example, all participants completing the everyday memory and cognitive failures 
tasks also completed the updating and inhibition executive tasks. 
<Insert Table 1 about here> 
Materials 
History of Drug Use. Patterns of drug use and other relevant lifestyle variables 
were investigated via means of a background questionnaire. The questionnaire gauged 
the use of cannabis and other drugs, as well as age, years of education, general health 
and other relevant lifestyle variables. In relation to illicit drugs, participants were 
asked a range of questions including frequency and duration of use and the last time 
that they had used each drug. Participants were also questioned concerning their 
history of drug use and these data were used to estimate total lifetime use of cannabis. 
Average weekly dose and the amount consumed within the previous 10 and 30 days 
were also assessed. Consumption of legal substances was also assessed. Participants 
were asked how many units of alcohol they consumed per week. Examples of what 
constituted a unit were provided, e.g., 1 glass of wine, a single measure of spirit, and 
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half pint of beer. Participants were also asked if they smoked and if so how many 
cigarettes per day they consumed. 
Measures of Executive functioning (Fisk & Sharp, 2004). 
Computation Span involved two elements, firstly participants were required to 
solve a simple arithmetic problem, for example, 7+3 = ?, by selecting the correct 
answer from among three alternatives; and secondly they were asked to recall the 
second digit of the problem (i.e., in the above example: 3).  As the task proceeded, the 
number of problems that had to be solved, while recalling the last digit of each, 
gradually increased.  Once all of the problems in a given set had been processed, the 
participant was asked to recall all of the second digits in the order in which they 
occurred.  The task commenced with three trials containing just a single problem, this 
was followed by three trials with two problems presented consecutively, and then 
three trials with three consecutive problems, and so on.  Span was defined as the 
maximum number of second digits successfully recalled in serial order. This level had 
to be achieved in at least two of the three relevant trials and the corresponding 
arithmetic problems had to be answered correctly. 
Random letter generation task. Participants were asked to speak aloud a letter 
each time they heard an auditory signal.  They were asked to avoid generating 
alphabetical sequences and repeat sequences such as AB or BBC.  They were also 
asked to try and produce each letter with the same overall frequency.  Each participant 
produced three sets of 100 letters, at the rate of one per second, one every two seconds 
and one every four seconds.  The order in which the sets were produced was 
randomised for each participant. The experimenter recorded participants’ responses. 
This task yields four separate measures for each generation rate. These are the total 
number of letters produced, the number of alphabetically ordered pairs, the number of 
times that any given letter pair is repeated, and redundancy, which is a measure of the 
extent to which each letter of the alphabet is produced equally often. Sequences 
containing relatively few letters that are repeated often, produce high redundancy. For 
each of these measures, the scores were standardised and averaged over the three 
generation rates thereby producing mean standardised scores for alphabetical 
sequences, repeat sequences, redundancy, and the total number of letters generated. 
For the first three of these a high score is associated with poor performance, for total 
number of letters a high score is indicative of efficient performance. 
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Fluid intelligence was measured via Raven’s Progressive Matrices (Raven et 
al, 1998), and premorbid intelligence was assessed via the National Adult Reading 
Test (NART, Nelson, 1982).   
Semantic Fluency: In the semantic fluency task, participants were required to 
produce as many animal names as they could think of. This could be different species, 
or breeds within species. Participants were given four minutes for this task.  
Chicago Word Fluency Test. Participants were instructed not to write any 
place names, peoples name or plurals in this test. Firstly participants were given five 
minutes to write down as many words as they could, beginning with the letter “S”. 
Secondly, they were given four minutes to write down as many four-letter words 
beginning with “C” as they could. As plurals were not allowed, words such as “cats”, 
and repetitions of words were excluded. Scores for all three fluency tasks were the 
number of appropriate words generated in each case. 
Plus-minus task. The plus-minus task, adapted from Miyake et al (2000) 
consists of three lists of 30 two-digit numbers (the numbers 10-99, randomised). On 
the first list, participants were instructed to add three to each number, and write their 
answer in the box next to it. On the second list, participants were instructed to subtract 
three from each number. On the third list, participants were required to alternately add 
and subtract three from the list (i.e. add three to the first number, subtract from the 
second, and so on). List completion times were measured with a stopwatch. The cost 
of shifting between adding and subtracting was calculated as the ratio between the 
time for list three and the average of the times for lists one and two.  
Number-Letter task. In the number-letter task, adapted from Miyake et al 
(2000), a number letter pair (e.g.D4) is presented in one of four quadrants on a 
computer screen. If the target is in the top half of the screen, the task is to indicate if 
the letter is a vowel (A, E, I, O or U) or a consonant. If the target is in the bottom half 
of the screen, the task is to indicate if the number is odd or even. The practise version 
of the task comprises three sets. The target is presented in the top half of the screen 
for 12 trials, then the bottom half for 12 trials, and then in a clockwise rotation around 
all 4 quadrants for a further 12 trials. The main task follows the same structure, except 
there are 64 targets in each block. Therefore, the trials in the first two blocks required 
no switching, while the third set did. The shift-cost was the ratio between the average 
reaction times of the third block and the averages of the first two blocks.   
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Associative Learning. This was assessed via a verbal paired-associates task 
(Montgomery et al 2005a). Participants were presented sequentially with the same 
eight word pairs on a computer screen. For example,  
  DOOR   CASE 
  YEAR   PAGE 
After each presentation, the participant was prompted with the first member of 
each pair and required to recall the second member. Eight such trials were 
administered. The order of presentation was randomised and changed for each trial. 
Measures included the number of correct responses in trial 1 (a measure of initial 
recall), forgetting, and the number of trials required to learn all associations.  
Everyday memory: The Everyday Memory Questionnaire (EMQ, Cornish, 
2000; Sunderland et al. 1983) is an established self-report measure of memory lapses 
in everyday activities. It consists of 27 statements, and in each case, participants 
respond on a 9-point scale ranging from “not at all in the last 6 months” to “more than 
once a day”. Statements include: “forgetting where you put something”; “finding a 
television story difficult to follow”; a total score for everyday memory is calculated 
by summing the responses to all items.  
Cognitive Failures: The Cognitive Failures Questionnaire (CFQ) measures the 
relationship between attentional performance and general cognitive functioning. The 
questions relate to different aspects of cognitive functioning and failure, such as 
perceptual failures (e.g. do you fail to notice signposts on the road?), misdirected 
actions (e.g. do you bump into people?) and memory failures (e.g. do you forget what 
you came to the shops to buy?). The term “cognitive failure” is an umbrella term to 
cover all three types of slip. Each questionnaire item required a number (0-4 
inclusive) to be circled. For each item, four corresponded to “very often” and 0 to 
“never”. There were 25 items in total yielding a maximum score of 100.  
To assess the accuracy of participants’ responses the Cognitive Failures 
Questionnaire for Others was also administered. This was completed by a ‘significant 
other’, i.e., someone who possessed a reasonable knowledge of the participant’s 
behavior in real world contexts. The participant’s significant other was asked: ‘During 
the last six months has your relative/partner/housemate seemed to be:’ after which 
eight items were presented, including for example, ‘Forgetful, such as forgetting 
where he/she has put things, or about appointments, or about what he/she has done?’ 
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The participant’s significant other responded on a 5 point scale with responses to half 
of the items beginning with “very often” and half with “never”. Following reversal of 
the scores as appropriate a total score was obtained by summing the scores to the 
individual items. This yielded a maximum score of 40. In the original study, 
Broadbent et al. used family members or partners of the participant, but due to the 
nature of student populations, in the present study we adopted the same approach as 
Smith-Spark et al (2004) and added “housemate” to the list of significant others. Total 
scores and percentage of slips reported were calculated to enable comparison between 
the two measures. 
Prospective memory (PM): This was assessed using the Prospective Memory 
Questionnaire (PMQ), which is an established self-report measure (Hannon et al., 
1995). The PMQ provides measures of three aspects of PM on a scale of 1-9 for each 
aspect. Fourteen questions measure short-term habitual PM, e.g. “I forgot to turn my 
alarm clock off when I got up this morning”. Fourteen items measure long-term 
episodic PM, e.g. “I forgot to pass on a message to someone”. Ten questions measure 
internally cued PM, e.g. “I forgot what I wanted to say in the middle of a sentence”. 
In addition, 14 questions make up the “techniques to remember” scale, which 
provides a measure of the number of strategies used to aid remembering. Responses 
on the PM scales ranged from 1 (never) to 9 (4 or more times a week/month/year) 
with the midpoint of the scale labelled ‘2 or more times a week/month/year’. For each 
of the 4 scales, a total score is calculated by summing the responses in each section, 
and dividing by the number of items in that section (14 for ST-habitual, LT-episodic 
and strategies, 10 for internally cued). Thus scores on all 4 scales ranged from 1-9 
with high scores being indicative of much forgetting, and many strategies used to aid 
remembering. 
Procedure 
Participants were informed of the general purpose of the Study, and written 
informed consent was obtained. The tests were administered under laboratory 
conditions, and a computer running MS-DOS was used for the computer based tasks.  
Participants were fully debriefed, paid 15 UK pounds in store vouchers, and given 
drugs education leaflets. The study was approved by the Ethics Committee of the 
University, and was administered in accordance with the ethical guidelines of the 
British Psychological Society. 
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The tests were administered in the following order: background questionnaire, 
random letter generation, paired associates learning task, computation span, NART, 
Raven’s progressive matrices, everyday memory, cognitive failures and the 
prospective memory questionnaires, the word fluency tests, and the number-letter and 
plus-minus tasks. Individual participants only completed a subset of the above 
measures. 
Design. All measures were analysed using a between participant design with 
user group with two levels (cannabis users and non users) as the independent variable. 
In relation to cognitive failures an additional analysis was performed with the source 
of the ratings within participants and user group between. Dependent variables were 
respectively the intelligence, executive function, learning, and real world memory 
measures. 
Statistics. Group differences in the background variables (intelligence, 
cigarettes consumed per day and units of alcohol per week) the executive function and 
learning measures were evaluated through ANOVA. Similarly ANOVA was used to 
evaluate group differences in the everyday memory and cognitive failures measures. 
In relation to prospective memory, MANOVA was utilised with the four measures as 
dependent variables. Subsequently ANOVAs were also conducted to evaluate group 
differences in the prospective memory individual measures.  
Where statistically significant group differences are obtained on the dependent 
variables, in those cases where the samples in question also differ significantly on the 
background measures, ANCOVA will be conducted with the relevant background 
measures as covariates. If there are any instances where the groups differ significantly 
on any of the executive or learning measures, ANCOVA will be conducted with the 
real world memory variables as dependent variables and the relevant executive and 
learning measures as covariates. This will shed light on the extent to which any 
cannabis-related differences in real world memory are due to group differences in the 
executive or learning measures. ANCOVA will also be used in order to explore 
whether any group differences in the various measures of real world memory have a 
common basis.  
 
RESULTS 
Indicators of cannabis use may be found in Table 1. Over the different samples 
mean lifetime cannabis use ranged between 470 to 1208 joints. Average weekly dose 
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ranged between 2.6 and 6.7 joints. There were no significant group differences with 
respect to the NART, F < 1 for all samples. The Ravens measure did not differ 
significantly between cannabis users and non users for those individuals completing 
the associative learning and word fluency measures.
1
 However cannabis users 
performed significantly better than non users on the Ravens measure for those 
samples completing the updating and inhibition executive tasks and the everyday 
memory and cognitive failures measures.
2
 Again compared to non users, cannabis 
users achieved higher Ravens scores in relation to the switching executive function 
sample and prospective memory sample, however, the group difference was just short 
of significance in both cases.
3
 
With regard to tobacco, Table 1 reveals that on average the number of 
cigarettes consumed each day was similar for both the cannabis user and nonuser 
groups. Only for the sample completing the switching executive function task was the 
group difference significant
4
. None of the other samples yielded significant group 
differences
5
.  Cannabis users generally consumed more alcohol (units per week) 
compared to nonusers. The difference was statistically significant for the updating, 
everday memory/cognitive failures, and prospective memory samples
6
. For the 
samples completing the access and switching executive function task and for the 
sample completing the associative learning task, the group differences were not 
statistically significant
7
 
Contrary to expectation inspection of Table 2 reveals that cannabis users did 
not differ significantly from nonusers on any of the measures of executive 
functioning. Neither were any group differences evident on the learning measures. 
Indeed generally the group means were in close proximity. Cannabis users exhibited 
slightly higher switch costs on the plus-minus and number-letter tasks. On the 
associative learning task cannabis users actually recalled more than non users on trial 
one.  However, these differences failed to reach significance. 
<Insert Table 2 about here> 
Means and standard deviations for the everyday memory and cognitive 
failures measures may be found in Table 2. Given that a high score is indicative of 
real world memory problems, it is clear that cannabis users performed worse on both 
measures. In fact users’ scores were roughly 20% higher on both measures. Given the 
significant difference on the Raven’s measure and in the level of alcohol consumed, 
ANCOVA was conducted for both memory measures with the Raven’s score and 
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units of alcohol consumed as covariates in both cases. The cannabis-related group 
difference remained significant with F(1,57) = 4.72, p = .034 for everyday memory 
and F(1,57) = 4.91, p = .031 for the cognitive failures measure. To investigate the 
basis of group differences on both memory measures two further ANCOVAs were 
conducted both with user group between participants. In the first analysis everyday 
memory was the dependent variable and the cognitive failures measure was the 
covariate. In the second analysis the measure of cognitive failures was the dependent 
variable and the everyday memory measure was the covariate. In both cases the 
cannabis group-related effect was reduced to below statistical significance, F < 1, with 
everyday memory as the dependent variable, and F(1,59) = 1.46, p = .232 with 
cognitive failures as the dependent variable. Thus it appears that the cannabis-related 
deficit in both measures may have some common basis. 
With regard to the CFQ-for-others, participants were given the questionnaire 
and asked to give it to their relative, partner, or housemate to complete. A pre-paid 
addressed envelope was provided for the participant’s significant other to return the 
questionnaire. In the event questionnaires were returned for 18 of the 29 nonusers and 
20 of the 33 users. Table 2 reveals that according to their significant others users were 
judged as producing more cognitive failures compared to nonusers. This difference 
approached significant, p = .065 (two tailed), and given that the prediction was 
directional, the outcome was significant on a one-tailed basis.  
For each participant the CFQ and the CFQ for-others scores were converted 
into proportions by dividing by the maximum possible score in both cases. On this 
basis the level (s.d.) of cognitive failures self reported by cannabis users and non users 
was respectively 41.65% (8.29) and 35.56% (10.95). However, the level (s.d.) of 
cognitive failures reported by significant others of cannabis users and non users was 
respectively 29.38% (9.06) and 24.17% (7.67). Thus in percentage terms significant 
others rated participants more favourably than the participants rated themselves. This 
was reflected in a significant effect of the source of the ratings, F(1,36) = 48.31, p = 
.000. However irrespective of the source of the ratings, in percentage terms, cannabis 
users exhibited a greater propensity for cognitive failures compared to nonusers, 
resulting in a significant effect of user group F(1,36) = 5.54, p = .024. The 
relationship between self ratings and ratings by significant others was virtually 
identical for both groups. Thus although there was a discrepancy between self and 
other ratings this discrepancy was similar in magnitude for both groups. Consistent 
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with this, ANOVA revealed that the interaction between the source of the ratings and 
user group was non significant, F < 1. Thus while all participants may overestimate 
the extent of their memory problems, there is no indication in the present results that 
users are less accurate than nonusers in assessing their propensity for cognitive 
failure. 
Switching the focus to prospective memory, means and standard deviations for 
the different aspects may be found in Table 2. MANOVA with user group between 
participants and the four prospective memory component measures as dependent 
variables yielded a significant main effect of group, Wilks’ lambda = .733, F(4,42) = 
3.82, p = .010. From inspection of Table 2, it is clear that cannabis users scored 
significantly lower on all four component measures. However, it is noteworthy that 
the mean scores were in the lower half of the range indicating that on average the 
magnitude of the problem was not excessive for either group. Nonetheless, cannabis 
users did exhibit a significant deficit on all dimensions especially on the techniques 
component subscale indicating that they felt the need to use far more memory aids so 
as to avoid forgetting. Thus to an extent, the scores on the other component subscales 
are bolstered by the application of the various techniques and strategies that are 
employed and so may understate the underlying level of the deficit among cannabis 
users. 
As noted above for those participants completing the prospective memory 
measure, cannabis users consumed significantly more alcohol compared to nonusers 
and the group difference on the Raven’s measure approached significance. In order to 
control for these group differences, a MANCOVA was conducted with the 
prospective memory component measures as dependent variables, group between 
participants, and the Raven’s scores and units of alcohol consumed as covariates. The 
multivariate effect was intensified following inclusion of the covariates, Wilks’ 
lambda = .654, F(4,40) = 5.29, p = .002. With regard to the component measures, 
following inclusion of the covariates, univariate analyses revealed that the group 
differences remained significant for the PM short term, Internally Cued  and 
Techniques subscales, F = 9.25, p = .004 ; F = 9.44, p = .004 ; and F = 17.34, p = .000  
respectively on 1, 43 d.f. < 1, and F(1,42) = 1.35, p = .252, respectively. For the PM 
Long Term subscale, the group difference approached significance F (1,43) = 3.70, p 
= .061.  
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In order to explore the relationship between the prospective memory scale and 
the measures of everyday memory and cognitive failures, the last two of these were 
included as covariates and a further MANCOVA was conducted with the prospective 
memory component measures as dependent variables and group between participants. 
The multivariate effect was reduced to a trend following inclusion of the covariates, 
Wilks’ lambda = .808, F(4,39) = 2.32, p = .074. With regard to the component 
measures, univariate analyses revealed that the group differences were no longer 
significant for the PM long term and Internally Cued components, F < 1, and F(1,42) 
= 1.35, p = .252, respectively. The cannabis-related deficit remained significant for 
the Short Term Habitual and the Techniques subscales, F = 4.26, p = .045 and F = 
8.98, p = .005, respectively on 1, 42 d.f. Thus there appears to be some commonality 
between those factors giving rise to the everyday memory problems, the cognitive 
failures, and some aspects of the prospective memory deficiencies. However, the 
univariate ANCOVA results suggest that the deficits on the short term habitual and 
the techniques subscales might in part relate to some other functionally separate 
factor. 
 
DISCUSSION 
The results obtained failed to reveal cannabis-related deficits in executive 
component processes and associative learning. However, cannabis use did appear to 
adversely affect real world memory functioning. Cannabis users were impaired on all 
three measures, everyday memory, cognitive failures, and prospective memory. The 
cannabis-related deficits in everyday memory and cognitive failures appeared to have 
a common basis in that the significant group effect in each was reduced to below 
statistical significance following inclusion of the other as a covariate. However, 
following the inclusion of the everyday memory and cognitive failures measures as 
covariates, the multivariate group effect in prospective memory although reduced, 
approached significance and the univariate outcomes for the PM Short Term Habitual 
and the PM Techniques measures remained statistically significant. Thus it appears 
that the cannabis-related group deficits in prospective memory are in some way 
distinct from those in everyday memory and cognitive failures.  
Prior to the present paper, Rodgers et al (2001) was the only study that we are 
aware of to examine real world memory processes in illicit drug users. In an Internet 
based study of poly-substance abusers, regression analysis revealed that the frequency 
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of cannabis use was significantly associated with impairments in everyday memory 
and in aspects of prospective memory (PM). More specifically the PM short term and 
PM internally cued subscales were found to be adversely related to cannabis use while 
PM long term was significantly and adversely related to ecstasy use (Rodgers et al, 
2001). The present results are broadly consistent with those of Rodgers et al. 
Everyday memory deficits were observed among cannabis-only users but unlike 
Rodgers et al our sample exhibited deficits in all aspects of prospective memory and 
in addition deficits in the CFQ measure were also observed. Furthermore on the CFQ-
Others measure, the degree of impairment among users was judged to be greater than 
that among nonusers by their respective significant others. The differing pattern of 
prospective memory outcomes reported by Rodgers et al and the present paper might 
be a product of the different characteristics of the two samples. It may be that the 
effects of cannabis in the context of polydrug use are different than is the case for 
cannabis-only users. 
Given that real world memory processes are known to be dependent on 
prefrontal executive resources (Marsh & Hicks, 1998; McDaniel et al, 1999; Whyte et 
al, 2006) cannabis-related deficits in real world memory might be taken as evidence 
of cannabis related deficits in executive functions. However, in this regard it is 
surprising that none of the laboratory measures of executive functioning and learning 
that were administered here were associated with cannabis-related deficits. It may be 
that while cannabis users are able to perform adequately in a laboratory setting, under 
the less controlled conditions that exist outside the laboratory, where there may be 
more distractions, users might demonstrate impairment. Thus it may be that were it 
possible to administer more ecologically valid executive function tasks in real world 
contexts cannabis-related deficits would be observed. Indeed other non-laboratory 
self-report measures have provided evidence of executive deficits. Verdejo-Garcia et 
al (2006) administered a multi-item rating scale measure which is believed to measure 
different aspects of prefrontal functioning including an executive component 
(planning, working memory, and mental flexibility) and an apathy component (loss of 
energy, poor initiation, blunted affective expression). The former is believed to rely 
on DLPFC resources and the latter on the anterior cingulate. It was found that the 
severity of cannabis use (an estimate based on the dose, frequency and length of use) 
significantly predicted outcomes on the executive and apathy subscales (Verdejo-
Garcia et al, 2006). 
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Thus the absence of executive deficits in the laboratory context does not 
necessarily imply that these processes are entirely intact. Indeed although cannabis 
users performed normally in the laboratory tasks administered here this does not 
imply that THC has no effect on the neural structures supporting these tasks. Jager et 
al (2007) asked their participants to perform an associative learning task. Utilising 
fMRI, lower activation levels among frequent cannabis users were observed in the 
medial temporal structures (especially the para-hippocampal area) and the right 
DLPFC. However, task performance was unaffected and voxel based morphometry 
revealed no structural differences in the regions of interest (ROI). Analogous results 
were obtained in an earlier study by the same authors (Jager et at, 2006). Frequent but 
moderate cannabis users performed similarly to nonusers in tests of working memory 
and visuo-auditory selective attention. However, fMRI revealed that while there were 
no differences in terms of overall patterns of brain activity a more specific analysis 
focussing on ROI revealed differences in brain activity between users and nonusers in 
the superior parietal cortex. Although outside the prefrontal cortex, the parietal cortex 
is known to play a role in a range of executive tasks (Collette et al, 2006). The 
significance of these altered patterns of neural activation among cannabis users 
remains unclear although it is possible that they might result in impaired performance 
under more demanding conditions. 
It is also possible that underlying deficits might have been apparent but that 
these were masked by other factors. For example Jacobsen et al (2007) note that most 
cannabis users also smoke tobacco and that the joint effects of these two psychoactive 
substances remains unclear. In a recent study they found that verbal memory and 
learning was impaired among adolescent cannabis users (but not nonusers) during a 
period of nicotine withdrawal. Through fMRI it was established that the impairment 
was associated with disrupted frontparietal connectivity. It is possible that nicotine 
and cannabis may interact in terms of their effects causing underlying memory 
impairments to be effectively masked in cannabis users (Jacobsen et al 2007). 
While the range of outcomes reported above are potentially important, it is 
appropriate to acknowledge a number of limitations in relation to the present findings. 
With respect to real world memory, with one exception the measures used were self-
report checklists. Clearly the results obtained must be viewed in the context of the 
reliability and validity of the instruments that were used. In this regard it is 
noteworthy that the results reported here from the CFQ-for-others demonstrated that 
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users were as accurate as nonusers in assessing their propensity for cognitive failures. 
This outcome is consistent with findings reported elsewhere for non clinical 
populations where a high level of agreement between self ratings and ratings by 
significant others has been obtained in relation to the real world memory (e.g., Hart et 
al, 2005; Olsson et al 2006; Smith-Spark et al, 2004). Beyond the issue of consistency 
with ratings by significant others, it has been demonstrated that the measure possesses 
internal consistency (Broadbent, et al 1982; Knight et al, 2004), retest reliability, face 
validity (Knight et al, 2004) and construct validity (Broadbent, et al 1982, Jones & 
Martin, 2003; Wallace, 2004; Wallace et al, 2002). The psychometric properties and 
construct validity of the everyday memory questionnaire (EMQ) have also been 
extensively explored in normal (Cornish, 2000) and clinical populations (Efklides et 
al, 2002; Koltai et al, 1996; Olsson et al, 2006; Schwartz & McMillan, 1989). Aspects 
of the EMQ were found to map onto discrete laboratory and real world memory 
measures and the utilisation of memory aids. Self ratings were highly correlated with 
ratings by significant others. Likewise the reliability and validity of Prospective 
Memory Questionnaire has been assessed (Hannon et al, 1995). 
With regard to the existence of cannabis-related differences, due to the quasi-
experimental design of the study, it is possible that the two groups may have differed 
on some variable other than cannabis use. Some possibilities have been excluded such 
as intelligence (NART) and the use of other illicit drugs. Group differences in other 
variables such as general health, nutrition, or some premorbid condition predating 
drug use (Verheul, 2001) cannot be ruled out. Furthermore, due to limited resources 
we were unable to provide an objective measure of recent drug use (e.g. from hair or 
urine samples). While this is clearly a limitation it is not without precedent. For 
example other studies testing cognitive deficits among ecstasy and cannabis users 
have not used these techniques relying instead on self reports (e.g. Croft et al, 2001; 
Morgan, 1998; Morgan, 1999; Rodgers, 2000). Furthermore, the drug history 
questionnaire (Montgomery et al 2005b) used in the research reported here has been 
developed so as to provide a number of tests of internal consistency and we have no 
reason to doubt the integrity of the information provided by the participants. 
Nonetheless the results reported in the present paper need to be assessed within the 
context of the limitations that have been noted. 
In conclusion, cannabis-related deficits in all aspects of real world memory 
were present. While no deficits were observed in laboratory tests of executive 
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function it remains possible that more ecologically valid tests of prefrontal processes 
might reveal cannabis-related differences. Further research is needed to explore the 
basis of cannabis related deficits in real world memory and their link with executive 
processes.  
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Table 1. Intelligence and Indicators of Cannabis Use 
 Updating and Inhibition 
Executive Functions: 
Computation Span and 
Random Generation 
Sample 
Access Executive Function: 
Word Fluency Sample 
Switching Executive 
Function: 
Plus/Minus-Number/Letter 
Task Samples 
 Mean S.D. n Mean S.D. n Mean S.D. n 
Cannabis Users   46   24   20 
    Ravens Progressive Matrices 50.20 4.79 45 49.46 4.85 24 49.85 5.12 20 
    NART 29.67 5.54 46 28.96 5.65 24 28.40 5.28 20 
    Units of Alcohol per Week 16.39 11.31 46 14.35 8.34 24 15.10 7.74 20 
    Cigarettes per day 2.36 4.24 46 1.48 3.83 24 2.00 3.68 20 
    Total Use (joints) 742.73 1151.60 28 1098.05 1549.80 11 469.67 728.03 9 
    Frequency of Use (times per week) 0.75 1.04 28 0.76 0.95 11 1.11 1.52 9 
    Use During Previous 10 Days (joints) 1.11 3.04 46 0.71 1.83 24 1.15 3.38 20 
    Use During Previous 30 Days (joints) 6.79 24.29 40 4.25 9.81 18 12.16 37.82 16 
    Average Weekly Dose (joints) 4.17 8.23 28 6.10 12.34 11 2.61 3.90 9 
    Length of Use (weeks) 189.72 136.98 45 200.23 161.61 23 152.25 96.54 20 
    Abstinence period   
    (weeks, Mean/Median/n) 
28.73 4 45 12.55 3 23 36.15 6 20 
Non-Cannabis Users   45   32   17 
    Ravens Progressive Matrices 47.18 5.32 45 47.21 5.05 32 46.65 5.15 17 
    NART 29.67 5.44 45 30.22 6.05 32 29.47 4.84 17 
    Units of Alcohol per Week 10.23 8.95 42 10.40 9.88 29 11.79 11.58 14 
    Cigarettes per day 1.33 3.90 45 1.88 4.53 32 0.00 0.00 17 
 
Some users were unable or unwilling to quantify their previous patterns of use. 
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Table 1. Intelligence and Indicators of Cannabis Use (Continued) 
 Everyday Memory and 
Cognitive Failures 
Sample 
Prospective Memory 
Sample 
Associative Learning Sample 
 Mean S.D. n Mean S.D. n Mean S.D. n 
Cannabis Users   33   27   16 
    Ravens Progressive Matrices 50.09 4.78 32 50.30 4.63 27 49.19 4.20 16 
    NART 29.42 5.63 33 29.81 5.94 27 29.69 6.31 16 
    Units of Alcohol per Week 17.58 12.90 33 17.33 13.79 27 13.47 9.67 16 
    Cigarettes per day 2.17 4.26 33 1.89 4.27 27 2.22 4.56 16 
    Total Use (joints) 782.57 1241.55 22 784.45 1242.18 19 1207.65 1588.06 10 
    Frequency of Use (times per week) 0.64 0.85 22 0.55 0.72 19 0.84 0.96 10 
    Use During Previous 10 Days (joints) 0.94 2.54 33 0.96 2.78 27 0.94 2.17 16 
    Use During Previous 30 Days (joints) 3.82 8.06 30 2.69 5.54 24 5.46 10.89 14 
    Average Weekly Dose (joints) 4.51 9.13 22 4.28 9.54 19 6.70 12.84 10 
    Length of Use (weeks) 208.72 151.16 32 214.26 150.69 27 251.62 171.80 15 
    Abstinence period   
    (weeks, Mean/Median/n) 
19.65 4 32 21.07 4 27 5.58 2 15 
Non-Cannabis Users   29   20   18 
    Ravens Progressive Matrices 47.07 5.02 29 47.65 4.39 20 46.94 4.72 18 
    NART 29.69 5.81 29 30.20 6.86 20 30.67 6.72 18 
    Units of Alcohol per Week 9.36 7.27 29 9.03 8.08 20 10.03 8.32 18 
    Cigarettes per day 2.07 4.73 29 3.00 5.48 20 3.33 5.69 18 
 
Some users were unable or unwilling to quantify their previous patterns of use. 
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Table 2. Performance on Executive Function, Associative Learning, and Real World Memory 
Measures for Cannabis Users and Non Users.  
 
 Cannabis 
Users 
Non Users F 
 Mean S.D. Mean S.D.  
Executive Function Tasks      
Random Letter Generation 
(standardised scores) 
     
          Alphabetic Sequences -0.04 0.67 -0.04 0.81 F < 1 
          Repeat Sequences 0.02 0.53 -0.06 0.72 F < 1 
          Redundancy -0.06 0.91 -0.05 0.71 F < 1 
          Number of Letters 
 
0.04 0.69 0.00 0.94 F < 1 
Computation Span  
 
4.43 1.41 4.58 1.63 F < 1 
Word Fluency      
          S letter 47.42 7.49 46.31 13.08 F < 1 
          C letter 15.79 4.70 16.56 6.26 F < 1 
          Semantic 44.63 11.08 43.09 8.92 F < 1 
 
Switching Tasks 
     
          Number – Letter ratio 1.70 0.35 1.58 0.34 F(1,35) = 1.04, p = .316 
          Plus-Minus Ratio 1.50 0.33 1.39 0.23 F(1,35) = 1.48, p = .233 
      
Associative Learning Task      
   Correct  Trial 1 5.06 1.84 4.17 2.26 F(1,32) = 1.58, p = .217 
   Trials to Completion 3.94 1.39 4.33 1.33 F < 1 
   Forgetting 0.63 0.96 0.83 1.29 F < 1 
 
Real World Memory Measures 
      
     Everyday Memory 87.67 32.29 71.86 23.84 F(1,60) = 4.70, p = .034 
     Cognitive Failures 43.55 15.40 35.76 10.24 F(1,60) = 5.34, p = .024 
     Cognitive Failures-for-Others 11.75 3.63 9.67 3.07 F(1.36) = 3.61, p = .065 
     Prospective Memory      
     Long Term Episodic 2.81 0.90 2.30 0.55 F(1,45) = 4.90, p =.032 
     Short Term Habitual 1.60 0.76 1.08 0.18 F(1,45) = 8.92, p = .005 
     Internally Cued 2.83 1.28 2.00 0.55 F(1,45) = 7.35, p = .009 
     Techniques 3.55 1.51 2.18 0.87 F(1,45) = 13.22, p = .001 
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1
 F(1,32) = 2.12, p = .155 and F(1,54) = 2.79, p = .100, respectively. 
2
 F(1,88) = 8.01, p = .006 and F(1,59) = 5.81, p = .019, respectively. 
3
 F(1,35) = 3.58, p = .067 and F(1,45) = 3.92, p = .054, respectively. 
4
 None of the nonuser group smoked cigarettes. Thus ANOVA was inappropriate. Instead one-sample t 
test revealed that the number of cigarettes smoked by cannabis users differed significantly from zero, t 
(df=19) = 2.43, p = .025. 
5
 F < 1 for all samples except those participants completing the updating executive task where F(1,89) 
= 1.44, p=.234. 
6
 F(1,86) = 7.95, p=.006; F(1,60) = 9.18, p = .004; and F(1,45) = 5.77, p = .020. respectively. 
7
 F(1,51) = 2.42, p=.126; F(1,32) = 1.01, p = ..324; and F(1,32) = 1.25, p = .272. respectively. 
 
